Feature | January 22, 2014

ProTom Proton Therapy Technology Tested in Michigan

ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy

Physicist measures Radiance 330 proton beam characteristics

ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy

Radiance 330 Proton System 250 MeV proton beam spot profile radial symmetry

ProTom International, Inc. Radiance 330 Proton Therapy Radiation Therapy

Radiance 330 Proton System Treatment Room at the McLaren Proton Therapy Center

January 22, 2014 — Physicists at the McLaren Proton Therapy Center (MPTC) in Flint, Michigan conducted clinical testing of ProTom International, Inc.’s Radiance 330 Proton Therapy System.
 
Radiance 330 employs the Proton Beam Scanning (PBS) treatment delivery technique, and the McLaren team tested key characteristics of the scanned beam delivered to instrumentation in water phantoms
 
“We have been impressed by the stability of the system during our testing,” said Sung Park, Ph.D., chief physicist at MPTC. “The spot size and spot profiles are well-described by a Gaussian distribution and demonstrate excellent radial symmetry. This bodes well for the dosimetry we can expect from ProTom's system.”
 
The U.S. Food and Drug Administration (FDA) has not yet cleared Radiance 330 Proton Therapy System for commercial distribution in the United States.
 

Related Content

IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Overlay Init